229 related articles for article (PubMed ID: 11323304)
1. Pre-erythrocytic immunity to Plasmodium falciparum: the case for an LSA-1 vaccine.
Kurtis JD; Hollingdale MR; Luty AJ; Lanar DE; Krzych U; Duffy PE
Trends Parasitol; 2001 May; 17(5):219-23. PubMed ID: 11323304
[TBL] [Abstract][Full Text] [Related]
2. Current Challenges in the Identification of Pre-Erythrocytic Malaria Vaccine Candidate Antigens.
Bettencourt P
Front Immunol; 2020; 11():190. PubMed ID: 32153565
[No Abstract] [Full Text] [Related]
3. Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3.
Daubersies P; Thomas AW; Millet P; Brahimi K; Langermans JA; Ollomo B; BenMohamed L; Slierendregt B; Eling W; Van Belkum A; Dubreuil G; Meis JF; Guérin-Marchand C; Cayphas S; Cohen J; Gras-Masse H; Druilhe P
Nat Med; 2000 Nov; 6(11):1258-63. PubMed ID: 11062538
[TBL] [Abstract][Full Text] [Related]
4. RTS,S/AS01E immunization increases antibody responses to vaccine-unrelated Plasmodium falciparum antigens associated with protection against clinical malaria in African children: a case-control study.
Dobaño C; Ubillos I; Jairoce C; Gyan B; Vidal M; Jiménez A; Santano R; Dosoo D; Nhabomba AJ; Ayestaran A; Aguilar R; Williams NA; Díez-Padrisa N; Lanar D; Chauhan V; Chitnis C; Dutta S; Gaur D; Angov E; Asante KP; Owusu-Agyei S; Valim C; Gamain B; Coppel RL; Cavanagh D; Beeson JG; Campo JJ; Moncunill G
BMC Med; 2019 Aug; 17(1):157. PubMed ID: 31409398
[TBL] [Abstract][Full Text] [Related]
5. Immunity to liver stage malaria: considerations for vaccine design.
Taylor-Robinson AW
Immunol Res; 2003; 27(1):53-70. PubMed ID: 12637768
[TBL] [Abstract][Full Text] [Related]
6. Anti-PfGARP activates programmed cell death of parasites and reduces severe malaria.
Raj DK; Das Mohapatra A; Jnawali A; Zuromski J; Jha A; Cham-Kpu G; Sherman B; Rudlaff RM; Nixon CE; Hilton N; Oleinikov AV; Chesnokov O; Merritt J; Pond-Tor S; Burns L; Jolly G; Ben Mamoun C; Kabyemela E; Muehlenbachs A; Lambert L; Orr-Gonzalez S; Gnädig NF; Fidock DA; Park S; Dvorin JD; Pardi N; Weissman D; Mui BL; Tam YK; Friedman JF; Fried M; Duffy PE; Kurtis JD
Nature; 2020 Jun; 582(7810):104-108. PubMed ID: 32427965
[TBL] [Abstract][Full Text] [Related]
7. Multiple antigen peptide vaccines against Plasmodium falciparum malaria.
Mahajan B; Berzofsky JA; Boykins RA; Majam V; Zheng H; Chattopadhyay R; de la Vega P; Moch JK; Haynes JD; Belyakov IM; Nakhasi HL; Kumar S
Infect Immun; 2010 Nov; 78(11):4613-24. PubMed ID: 20823210
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
[TBL] [Abstract][Full Text] [Related]
9. Blood stage vaccines for Plasmodium falciparum: current status and the way forward.
Ellis RD; Sagara I; Doumbo O; Wu Y
Hum Vaccin; 2010 Aug; 6(8):627-34. PubMed ID: 20519960
[TBL] [Abstract][Full Text] [Related]
10. Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection.
Cummings JF; Spring MD; Schwenk RJ; Ockenhouse CF; Kester KE; Polhemus ME; Walsh DS; Yoon IK; Prosperi C; Juompan LY; Lanar DE; Krzych U; Hall BT; Ware LA; Stewart VA; Williams J; Dowler M; Nielsen RK; Hillier CJ; Giersing BK; Dubovsky F; Malkin E; Tucker K; Dubois MC; Cohen JD; Ballou WR; Heppner DG
Vaccine; 2010 Jul; 28(31):5135-44. PubMed ID: 19737527
[TBL] [Abstract][Full Text] [Related]
11. Antibody profiles to wheat germ cell-free system synthesized Plasmodium falciparum proteins correlate with protection from symptomatic malaria in Uganda.
Kanoi BN; Takashima E; Morita M; White MT; Palacpac NM; Ntege EH; Balikagala B; Yeka A; Egwang TG; Horii T; Tsuboi T
Vaccine; 2017 Feb; 35(6):873-881. PubMed ID: 28089547
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
Lalitha PV; Biswas S; Pillai CR; Saxena RK
Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
[TBL] [Abstract][Full Text] [Related]
13. Plasmodium falciparum liver-stage antigen-1 peptide-specific interferon-gamma responses are not suppressed during uncomplicated malaria in African children.
Luty AJ; Bongartz M; Rezbach P; Faucher JF; Hollingdale MR; Kremsner PG
Eur Cytokine Netw; 2001; 12(4):647-53. PubMed ID: 11781192
[TBL] [Abstract][Full Text] [Related]
14. Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection.
John CC; Moormann AM; Pregibon DC; Sumba PO; McHugh MM; Narum DL; Lanar DE; Schluchter MD; Kazura JW
Am J Trop Med Hyg; 2005 Jul; 73(1):222-8. PubMed ID: 16014863
[TBL] [Abstract][Full Text] [Related]
15. The march toward malaria vaccines.
Hoffman SL; Vekemans J; Richie TL; Duffy PE
Vaccine; 2015 Nov; 33 Suppl 4(Suppl 4):D13-23. PubMed ID: 26324116
[TBL] [Abstract][Full Text] [Related]
16. Malaria vaccines based on the Plasmodium falciparum merozoite surface protein 3--should we avoid amino acid sequence polymorphisms or embrace them?
Saul A
J Infect Dis; 2007 Jan; 195(2):171-3. PubMed ID: 17191161
[No Abstract] [Full Text] [Related]
17. Pre-erythrocytic malaria vaccines to prevent Plasmodium falciparum malaria.
Ballou WR; Kester KE; Heppner DG
Chem Immunol; 2002; 80():253-61. PubMed ID: 12058643
[No Abstract] [Full Text] [Related]
18. Process development and analysis of liver-stage antigen 1, a preerythrocyte-stage protein-based vaccine for Plasmodium falciparum.
Hillier CJ; Ware LA; Barbosa A; Angov E; Lyon JA; Heppner DG; Lanar DE
Infect Immun; 2005 Apr; 73(4):2109-15. PubMed ID: 15784552
[TBL] [Abstract][Full Text] [Related]
19. Effect of transmission intensity and age on subclass antibody responses to Plasmodium falciparum pre-erythrocytic and blood-stage antigens.
Noland GS; Jansen P; Vulule JM; Park GS; Ondigo BN; Kazura JW; Moormann AM; John CC
Acta Trop; 2015 Feb; 142():47-56. PubMed ID: 25446174
[TBL] [Abstract][Full Text] [Related]
20. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2.
Wizel B; Houghten RA; Parker KC; Coligan JE; Church P; Gordon DM; Ballou WR; Hoffman SL
J Exp Med; 1995 Nov; 182(5):1435-45. PubMed ID: 7595214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
